Intravenous push medications in the home

Area of Science:

• Pharmacology and Pharmaceutics
• Nursing and Patient Care
• Health Services Research

Background:

• Evaluating economical and safe drug delivery methods is crucial for quality patient outcomes.
• Intravenous (IV) push administration is a recognized method, but its comparison with other methods in home settings warrants investigation.
• Self-administration of anti-infectives in the home setting requires careful consideration of drug delivery efficiency and safety.

Observation:

• A comparative analysis of 1116 case reports from 50 sites examined minibag versus IV push drug delivery for home anti-infective self-administration.
• Ceftriaxone, cefazolin, and ceftazidime were the most frequently administered anti-infectives in the study.
• Overall complication rates were 1.89/1000 catheter days for IV push and 1.69/1000 catheter days for minibag delivery.

Findings:

• The minibag delivery method demonstrated a slightly lower overall complication rate (1.69/1000 catheter days) compared to IV push (1.89/1000 catheter days).
• Phlebitis rates were comparable, with 0.6/1000 catheter days for IV push and 0.79/1000 catheter days for minibag delivery.
• Client satisfaction levels were similar across all evaluated drug delivery methods.

Implications:

• Both IV push and minibag methods are viable options for home anti-infective self-administration, offering comparable patient satisfaction.
• The findings suggest that minibag infusion may offer a marginal benefit in reducing overall complications in home-based anti-infective therapy.
• Further research can explore optimizing drug delivery protocols to enhance safety and efficiency in home healthcare settings.